Bank of Montreal’s Editas Medicine EDIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-12,370
Closed -$91.8K 4045
2023
Q1
$91.8K Buy
+12,370
New +$110K ﹤0.01% 3257
2022
Q4
Sell
-36,852
Closed -$468 4050
2022
Q3
$468 Sell
36,852
-10,715
-23% -$167K ﹤0.01% 2623
2022
Q2
$655 Sell
47,567
-4,016
-8% -$53.8K ﹤0.01% 2540
2022
Q1
$1.01M Buy
+51,583
New +$959K ﹤0.01% 2325
2021
Q4
Sell
-8,580
Closed -$365K 3584
2021
Q3
$365K Buy
+8,580
New +$470K ﹤0.01% 3044
2021
Q2
Sell
-4,208
Closed -$172K 4012
2021
Q1
$172K Sell
4,208
-7,224
-63% -$412K ﹤0.01% 3178
2020
Q4
$879K Buy
11,432
+7,387
+183% +$303K ﹤0.01% 2332
2020
Q3
$116K Sell
4,045
-1,350
-25% -$44K ﹤0.01% 3000
2020
Q2
$186K Buy
5,395
+4,620
+596% +$121K ﹤0.01% 2771
2020
Q1
$15K Sell
775
-6,355
-89% -$160K ﹤0.01% 3345
2019
Q4
$211K Buy
7,130
+464
+7% +$11.6K ﹤0.01% 3132
2019
Q3
$152K Buy
6,666
+608
+10% +$15.1K ﹤0.01% 3074
2019
Q2
$150K Buy
6,058
+4,508
+291% +$108K ﹤0.01% 3086
2019
Q1
$37K Buy
1,550
+348
+29% +$7.88K ﹤0.01% 3455
2018
Q4
$28K Sell
1,202
-294
-20% -$8K ﹤0.01% 3510
2018
Q3
$48K Sell
1,496
-193
-11% -$6.24K ﹤0.01% 3408
2018
Q2
$61K Buy
1,689
+959
+131% +$34K ﹤0.01% 3339
2018
Q1
$24K Buy
730
+250
+52% +$8.91K ﹤0.01% 3501
2017
Q4
$15K Sell
480
-420
-47% -$10.6K ﹤0.01% 3663
2017
Q3
$21K Buy
900
+300
+50% +$5.71K ﹤0.01% 3498
2017
Q2
$10K Hold
600
﹤0.01% 3706
2017
Q1
$13K Hold
600
﹤0.01% 3480
2016
Q4
$9K Hold
600
﹤0.01% 3625
2016
Q3
$8K Buy
+600
New +$12.3K ﹤0.01% 3598

Other funds holding EDIT

Bank of Montreal's EDIT Position: Q2 2023 in Review

Bank of Montreal sold out of Editas Medicine (EDIT) in Q2 2023, closing a stake of 12,370 shares — an estimated $91.8K sold.

Bank of Montreal first reported a position in EDIT in Q3 2016 and held it in 24 quarters. The position peaked at $1.01M in Q1 2022. 238 funds tracked by Wall St. Rank hold EDIT as of Q2 2023.

  • Bank of Montreal reported no remaining Editas Medicine position as of Q2 2023 after selling out during the quarter.
  • Bank of Montreal sold 12,370 Editas Medicine shares in Q2 2023, an estimated $91.8K.
  • Bank of Montreal first reported a position in Editas Medicine in Q3 2016 and held it in 24 quarters.
  • Bank of Montreal's Editas Medicine position peaked at $1.01M in Q1 2022.
  • 238 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2023.

Based on Bank of Montreal's 13F filing for Q2 2023, filed 2 Aug 2023.